fa
Feedback
Market & You

Market & You

رفتن به کانال در Telegram

SEBI Mandatory Guidelines Group Disclaimer/ disclosures 👉This group do not provide any tips/recommendations/advice/paid advisory services. 👉This group may or may not have SEBI regitered advisors. 👉All updates/posts/discussions are only for educational

نمایش بیشتر
517
مشترکین
اطلاعاتی وجود ندارد24 ساعت
-27 روز
-630 روز
آرشیو پست ها
#Ace
#Ace

Deepak Ntr CMP: 1740 Good to add till 1700 Weak below : 1670 Upside potential: 1870-1900 Disclaimer: Holding from lower level
Deepak Ntr CMP: 1740 Good to add till 1700 Weak below : 1670 Upside potential: 1870-1900 Disclaimer: Holding from lower levels

POLYCAB INDIA: Q1 CONS NET PROFIT 7.8B RUPEES VS 5.9B (YOY); EST 7.13B POLYCAB INDIA: Q1 EBITDA 11.36B RUPEES VS 8.58B (YOY); EST 10.6B || Q1 EBITDA MARGIN 13.84% VS 14.52% (YOY); EST 13.4% POLYCAB INDIA: Q1 REVENUE 82.1B RUPEES VS 59B (YOY); EST 79.02B

ITC HOTELS: Q1 CONS NET PROFIT 1.8B RUPEES VS 1.33B (YOY) ITC HOTELS: Q1 REVENUE 9.4B RUPEES VS 8.2B (YOY) ITC HOTELS: Q1 EBITDA 2.96B RUPEES VS 2.48B (YOY) || Q1 EBITDA MARGIN 31.62% VS 30.5% (YOY)

Sky gold 600+ , 50 % move almost

Glenmark pharma CMP: 2225 Good to add till 2150-2180 Weak below : Daily close below 2130 Upside potential: 2380, 2450+
Glenmark pharma CMP: 2225 Good to add till 2150-2180 Weak below : Daily close below 2130 Upside potential: 2380, 2450+

Stock name Glenmark pharma

After Mankind pharma another pharma stock on radar, Stay tuned for update

photo content

Deepak Fertilizer 920 to 1670+ till now

Minda corp made a low of 640 now made a high of 709, T1 almost completed

Ace 850 to 1040+

Mankind now @ 2600+, 2320 to 2600+, 12 % return so far

Mankind pharma 2540+

Minda Corp (Weekly) Range Breakout CMP: 664 dips can be accumulated till 630-640 Upside potential 710, 750 View invalid below
Minda Corp (Weekly) Range Breakout CMP: 664 dips can be accumulated till 630-640 Upside potential 710, 750 View invalid below a weekly close below 620 Disclaimer: Part of my portfolio Not a Buy sell recommendation, DYOR

Mankind pharma CMP: 2320 Good to add till 2260 Upside potential: 2450, 2500 & 2600+ View invalid below : 2200 Do your own Res
Mankind pharma CMP: 2320 Good to add till 2260 Upside potential: 2450, 2500 & 2600+ View invalid below : 2200 Do your own Research not a Buy sell recommendation

Sky gold up 6% ahead of good numbers

Banco India 580 to 682+

DEEPAK FERTILISERS Q4 CONSOLIDATED RESULTS 📊 • Net Profit ₹139.39 Cr ↓ 49.8% YoY, ↓ 1.5% QoQ • Revenue ₹3,011.38 Cr ↑ 12.9% YoY, ↑ 6.4% QoQ • EBITDA ₹353.99 Cr ↓ 26.3% YoY, ↑ 0.2% QoQ • Margins 11.75% vs 18.00% YoY, 12.48% QoQ ↓ • Dividend ₹10/share announced

Booked profit @ 491